For generations, the female hormonal cycle was treated as a private, almost shameful matter, and that omission had an evident clinical cost. The historical exclusion of women from medical trials delayed the diagnosis of conditions such as ADHD, whose symptoms fluctuate with estrogen and progesterone. Today, that reality is beginning to come to light. The public conversation is no longer a whisper, but a demand for diagnostic and therapeutic precision for half the population that deserves answers.
Tracking apps and algorithms: technology adapts to the cycle 📱
Technological development is moving toward personalized female medicine. Menstrual health apps no longer just record dates; they integrate variables such as energy, sleep, and cognitive state to correlate them with the hormonal phase. This data, processed with machine learning algorithms, makes it possible to adjust doses of psychostimulant medications for ADHD according to the week of the cycle. However, a challenge remains: the clinical validation of these tools. The industry must demonstrate real efficacy, not just offer pretty charts, for professionals to trust them.
The wise ovary: when your calendar decides your medication 🤖
It turns out that ovulation has more decision-making power than your psychiatrist. One week a month, your methylphenidate dose works like an expensive placebo, and the next, you feel as if you had drunk triple coffee. The irony is that meanwhile, your phone's algorithm knows exactly when you are going to be irritable, but your doctor still does not consult it. So now you know: if you want your treatment adjusted, do not book an appointment, wait for your app to recommend it. Science advances, but so does humor.